The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Fair enough, so you attended this presentation and heard Gooding deliver it?
I just hadn't heard about it and wondered why it was not open to everyone? It sounds like he was delivering some pretty relevant information there. As you quoted:
"Major licensee technical objections regarding viability of NXP002 as an inhaled therapy are now addressed..." that's quite a thing. Who is the major licensee?
Exactly when in December did this take place, if you don't mind spoonfeeding me just a little more?
It literally tells you where I got it FX, not sure why I need to spoon feed people.
Companies make documents for different purposes.
If it's official then why is it not on their website? Surely such a presentation should be available to all shareholders, existing and prospective.
Can you not say where you found this document?
Certainly is legit fx.
Moneybags, it came from research. It’s not difficult to figure out where.
Where has this document come from?
Are you saying this is a legitimate document?
Lol.. actually not Fx
LOL! Is that what they added then they updated the website the other day 😂
Yes the 2200 % increase 😴
Hi NFTs, How's AVCT done since you told us to buy it at 135p?
Yawn 🥱
I'm enjoying that this is being called the "Gooding Declaration"
https://shorturl.at/bhkqB
"Major licensee technical objections regarding viability of NXP002 as an inhaled therapy are now addressed..."
Hope so FX.
“… We expect the European grant to follow shortly, which will further support the Company's on-going partnering activities.”
If the US, Japan & EU are 'in the bag' then presumably, from a patent viewpoint, there is nothing to hold a partner back now?
You said they have all the data they need, just beefing it up.
So, no excuses now!
Certainly helps to have the patents granted.
NXP002 now has approvals in US, Japan and EU.
Does anyone think that any deal may hinge on patents being approved prior to transaction? If so this is a good sign.
On a positive note, the 'intention to grant' for the European Patent of NXP002 has now come through.
https://patentscope.wipo.int/search/en/detail.jsf?docId=EP328059213&_cid=P21-LS8UKP-85805-1
The thought behind it being a market maker holding the warrants is along the line of;
The warrants were issued as part of the fund raising last year. So the company raise an amount of cash up front, but don’t get the cash for the warrants till they’re exercised.
Typically this would be out of the companies control as to when it happens, but if they are held by a MM, there could be an agreement that they can be exercised at the company’s request as and when they needed the money.
So Peel (or another MM) hold the warrants and are exempt from notification.
NFX tell them when they need the monies released.
The MM then forward sells into the market, raising the cash to give to the company.
The warrants are later exercised and the MM has the shares to hand again without having to declare a holding.
Whoever it is, the normal rules don't seem to apply
For me it’s more expecting to see an ‘exercise of warrants’ rns.
I have a sneaky feeling PEEL are somehow involved.
As a market maker they don’t have to declare a holding until it’s above 10%
No TR1's then. Is it now safe to assume our invisible 'institutional investor' has managed to exercise and dumped everything in one transaction, so they don't have to?
I sometimes wonder if this market is regulated at all.
Probably just let Go-Daddy know it's still in use
Always makes me smile when there is a tiny and insignificant website update undertaken, but hey its been a year in the making.
One page has had one minor change on the 1st Feb at 12.30pm.
Must have been a quiet lunchtime.
If it is the warrants being forward sold, I don’t know how much time they would have before exercising the warrants. That’s part of the dark arts of the market.
Only Dan would have to notify on the same day.
Jo Holland isn’t a director anymore so only has to declare as a major holder, which I think is after 2 days